| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.00071 | 1 |